US Nuclear Corp. (UCLE)
OTCMKTS · Delayed Price · Currency is USD
0.0205
-0.0030 (-12.77%)
At close: Oct 21, 2026
US Nuclear Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2.04 | 2.17 | 2.19 | 2.23 | 2.09 | 2.14 | |
Revenue Growth | 0.25% | -0.98% | -1.82% | 6.68% | -2.16% | 21.94% |
Cost of Revenue | 1.15 | 1.08 | 1.17 | 1.31 | 1.3 | 0.76 |
Gross Profit | 0.9 | 1.09 | 1.02 | 0.92 | 0.79 | 1.38 |
Selling, General & Admin | 1.33 | 1.9 | 2.55 | 2.57 | 2.28 | 2.74 |
Operating Expenses | 1.33 | 1.9 | 2.55 | 2.57 | 2.28 | 2.74 |
Operating Income | -0.43 | -0.81 | -1.54 | -1.64 | -1.5 | -1.36 |
Interest Expense | -0.17 | -0.16 | -0.23 | -1.65 | -0.55 | -0.01 |
Earnings From Equity Investments | - | - | - | -0.01 | - | -0.84 |
Other Non Operating Income (Expenses) | -0.14 | -0.14 | 0.02 | -0.05 | - | 0 |
EBT Excluding Unusual Items | -0.74 | -1.11 | -1.74 | -3.35 | -2.04 | -2.21 |
Impairment of Goodwill | -0.13 | -0.13 | - | - | - | - |
Gain (Loss) on Sale of Assets | - | - | - | -0 | - | - |
Other Unusual Items | - | - | - | -0.08 | - | 0.33 |
Pretax Income | -0.87 | -1.24 | -1.74 | -3.43 | -2.04 | -1.88 |
Net Income | -0.87 | -1.24 | -1.74 | -3.43 | -2.04 | -1.88 |
Preferred Dividends & Other Adjustments | 0.25 | 0.23 | 0.07 | 0 | 0.02 | 0.05 |
Net Income to Common | -1.12 | -1.47 | -1.81 | -3.44 | -2.06 | -1.93 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 62 | 60 | 47 | 36 | 30 | 27 |
Shares Outstanding (Diluted) | 62 | 60 | 47 | 36 | 30 | 27 |
Shares Change | 22.54% | 29.34% | 29.68% | 22.22% | 7.78% | 23.98% |
EPS (Basic) | -0.02 | -0.02 | -0.04 | -0.10 | -0.07 | -0.07 |
EPS (Diluted) | -0.02 | -0.02 | -0.04 | -0.10 | -0.07 | -0.07 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -0.23 | -0.2 | -0.51 | -0.26 | -1.32 | -0.45 |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.01 | -0.04 | -0.02 |
Gross Margin | 43.84% | 50.27% | 46.37% | 41.43% | 37.68% | 64.40% |
Operating Margin | -21.08% | -37.30% | -70.09% | -73.58% | -71.53% | -63.73% |
Profit Margin | -54.64% | -67.93% | -82.83% | -154.00% | -98.53% | -90.27% |
Free Cash Flow Margin | -11.42% | -9.19% | -23.24% | -11.85% | -63.31% | -20.93% |
EBITDA | -0.43 | -0.81 | -1.53 | -1.64 | -1.49 | -1.36 |
EBITDA Margin | -21.00% | -37.23% | -69.98% | -73.44% | -71.38% | -63.61% |
D&A For EBITDA | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -0.43 | -0.81 | -1.54 | -1.64 | -1.5 | -1.36 |
EBIT Margin | -21.08% | -37.30% | -70.08% | -73.58% | -71.53% | -63.73% |